FDA product code QBR: Intranasal Electrostimulation Device For Dry Eye Symptoms

QBR is the FDA product code for intranasal electrostimulation device for dry eye symptoms. It is a Class II device, regulated under 21 CFR 886.5310 and reviewed by the Ophthalmic panel. FDA has cleared 1 510(k) submission under QBR. The average 510(k) review took 252 days (median 252). 1 De Novo request was granted under it.

Definition

This device type is intended to temporarily increase tear production using neurostimulation to improve dry eye symptoms. For prescription use only.

Classification

FieldValue
Device nameIntranasal Electrostimulation Device For Dry Eye Symptoms
Device classClass II
Regulation21 CFR 886.5310
Review panelOP — Ophthalmic
Medical specialtyOphthalmic
Premarket route510(k)

510(k) clearances per year for QBR

YearClearancesAvg. review days
20201252

Compare with all 510(k) review times · Search every QBR clearance

Top QBR applicants

ApplicantClearancesLatest
Allergan12020-08-31

Most recent QBR clearances

510(k)ApplicantDeviceDecision dateReview days
K193589AllerganTrueTear Intranasal Tear Neurostimulator2020-08-31252

Recalls for QBR devices

openFDA lists no recalls for product code QBR.

Frequently asked questions

What is FDA product code QBR?

QBR is the FDA product code for intranasal electrostimulation device for dry eye symptoms. It is a Class II device, regulated under 21 CFR 886.5310 and reviewed by the Ophthalmic panel.

What device class is QBR?

Class II, regulation 21 CFR 886.5310. Typical premarket route: 510(k).

How long does a 510(k) take for product code QBR?

Across 1 cleared submissions the average was 252 days from receipt to decision (median 252).

Which companies have the most QBR clearances?

Allergan (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Ophthalmic product codes · FDA product code lookup · 510(k) database search · 510(k) review times